Data Science Funding Announcements & Notices
Data science and informatics funding announcements and notices are available from NCI and NIH programs. Browse below for opportunities, requests for information, notices, and initiatives.
| Title Sort descending | FOA | Organization | Release Date | Expire Date | Purpose |
|---|---|---|---|---|---|
| Bat Immunology Network Research Resource Program (U24 Clinical Trial Not Allowed) | RFA-AI-23-069 | NIAID | The purpose of this Notice of Funding Opportunity (NOFO) is to support the development and validation of reagents/tools to support research to characterize cellular and molecular constituents of the… More | ||
| Behavioral and Integrative Treatment Development Program (R01 Clinical Trial Optional) | PAR-22-182 | NIDA | The purpose of this funding opportunity announcement (FOA) is to encourage behavioral intervention development research to test efficacy, conduct clinical trials, examine mechanisms of behavior… More | ||
| Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional) | PAR-22-183 | NIDA | The purpose of this funding opportunity announcement (FOA) is to encourage behavioral intervention development research to test efficacy, conduct clinical trials, examine mechanisms of behavior… More | ||
| Bioengineering Partnerships with Industry (U01 Clinical Trial Optional) | PAR-22-123 | NIBIB | This Funding Opportunity Announcement (FOA) solicits applications from research partnerships formed by academic and industrial investigators to accelerate the development and adoption of promising… More | ||
| Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed) | PAR-22-242 | NCI | The purpose of this funding opportunity announcement is to encourage collaborations between the life and physical sciences that: 1) apply a multidisciplinary bioengineering approach to the solution… More | ||
| Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional) | PAR-22-243 | NCI | The purpose of this funding opportunity announcement is to encourage collaborations between the life and physical sciences that: 1) apply a multidisciplinary bioengineering approach to the solution… More | ||
| Biological Testing Facility (X01 Clinical Trial Not Allowed) | PAR-23-192 | NICHD | The purpose of this funding opportunity announcement (FOA) is to provide investigators with a mechanism to request services from this facility that would advance their contraceptive development… More | ||
| Biology of Bladder Cancer (R01 Clinical Trial Optional) | PAR-22-218 | NCI | This Funding Opportunity Announcement (FOA) solicits applications investigating the biology and underlying mechanisms of bladder cancer. Bladder cancer is a significant health problem both in the… More | ||
| Biology of Bladder Cancer (R21 Clinical Trial Optional) | PAR-22-219 | NCI | This Funding Opportunity Announcement (FOA) solicits applications investigating the biology and underlying mechanisms of bladder cancer. Bladder cancer is a significant health problem both in the… More | ||
| Biomedical Technology Optimization and Dissemination Center (BTOD)(RM1-Clinical Trial Not Allowed) | PAR-23-110 | NIGMS | This Funding Opportunity Announcement (FOA) encourages applications for NIGMS Biomedical Technology Optimization and Dissemination (BTOD) Centers to support late-stage technology optimization and… More |